+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Botox Market 2024-2028

  • PDF Icon

    Report

  • 154 Pages
  • January 2024
  • Region: Global
  • TechNavio
  • ID: 5513567
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The botox market is forecasted to grow by USD 4.58 bn during 2023-2028, accelerating at a CAGR of 9.66% during the forecast period. The report on the botox market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing applications of botox in cosmetic and therapeutic procedures, rising demand for minimally invasive procedures, and increasing use of botox in dentistry.

The botox market is segmented as below:

By Application

  • Aesthetic
  • Medical

By End-user

  • Hospitals
  • Dermatology clinics
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing importance of medical aesthetics as one of the prime reasons driving the botox market growth during the next few years. Also, increasing demand for preventive cosmetic treatments and growing demand from men for facial aesthetics will lead to sizable demand in the market.

The report on the botox market covers the following areas:

  • Botox market sizing
  • Botox market forecast
  • Botox market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading botox market vendors that include AbbVie Inc., Bausch Health Companies Inc., BTXA, Candela Corp., Daewoong Bio Inc., Eisai Co. Ltd., Evolus Inc, FASTOX Pharma, Galderma SA, Hugel Inc, Huons Global, Ipsen Pharma, MedyTox Co. Ltd., Merz Pharma GmbH and Co KGaA, NEXUS LIFECARE PVT. LTD., Object Pharma Inc., Revance Therapeutics Inc., SciVision Biotech Inc., Suneva Medical, and USWM LLC. Also, the botox market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global botox market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global botox market 2018 - 2022 ($ billion)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Aesthetic - Market size and forecast 2023-2028
Exhibit 34: Chart on Aesthetic - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Aesthetic - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Aesthetic - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Aesthetic - Year-over-year growth 2023-2028 (%)
6.4 Medical - Market size and forecast 2023-2028
Exhibit 38: Chart on Medical - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Medical - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Medical - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Medical - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
Exhibit 42: Market opportunity by Application ($ billion)
Exhibit 43: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2023-2028
Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.4 Dermatology clinics - Market size and forecast 2023-2028
Exhibit 52: Chart on Dermatology clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Dermatology clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Dermatology clinics - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Dermatology clinics - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ billion)
Exhibit 61: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Brazil - Market size and forecast 2023-2028
Exhibit 87: Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Brazil - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
9.9 Japan - Market size and forecast 2023-2028
Exhibit 91: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.10 Mexico - Market size and forecast 2023-2028
Exhibit 95: Chart on Mexico - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Mexico - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Mexico - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
9.11 Germany - Market size and forecast 2023-2028
Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 111: AbbVie Inc. - Overview
Exhibit 112: AbbVie Inc. - Product / Service
Exhibit 113: AbbVie Inc. - Key news
Exhibit 114: AbbVie Inc. - Key offerings
12.4 BTXA
Exhibit 115: BTXA - Overview
Exhibit 116: BTXA - Product / Service
Exhibit 117: BTXA - Key offerings
12.5 Daewoong Bio Inc.
Exhibit 118: Daewoong Bio Inc. - Overview
Exhibit 119: Daewoong Bio Inc. - Product / Service
Exhibit 120: Daewoong Bio Inc. - Key offerings
12.6 Evolus Inc
Exhibit 121: Evolus Inc - Overview
Exhibit 122: Evolus Inc - Product / Service
Exhibit 123: Evolus Inc - Key offerings
12.7 FASTOX Pharma
Exhibit 124: FASTOX Pharma - Overview
Exhibit 125: FASTOX Pharma - Product / Service
Exhibit 126: FASTOX Pharma - Key offerings
12.8 Galderma SA
Exhibit 127: Galderma SA - Overview
Exhibit 128: Galderma SA - Product / Service
Exhibit 129: Galderma SA - Key news
Exhibit 130: Galderma SA - Key offerings
12.9 Hugel Inc
Exhibit 131: Hugel Inc - Overview
Exhibit 132: Hugel Inc - Product / Service
Exhibit 133: Hugel Inc - Key offerings
12.10 Huons Global
Exhibit 134: Huons Global - Overview
Exhibit 135: Huons Global - Product / Service
Exhibit 136: Huons Global - Key offerings
12.11 Ipsen Pharma
Exhibit 137: Ipsen Pharma - Overview
Exhibit 138: Ipsen Pharma - Business segments
Exhibit 139: Ipsen Pharma - Key offerings
Exhibit 140: Ipsen Pharma - Segment focus
12.12 MedyTox Co. Ltd.
Exhibit 141: MedyTox Co. Ltd. - Overview
Exhibit 142: MedyTox Co. Ltd. - Product / Service
Exhibit 143: MedyTox Co. Ltd. - Key offerings
12.13 Merz Pharma GmbH and Co KGaA
Exhibit 144: Merz Pharma GmbH and Co KGaA - Overview
Exhibit 145: Merz Pharma GmbH and Co KGaA - Product / Service
Exhibit 146: Merz Pharma GmbH and Co KGaA - Key offerings
12.14 NEXUS LIFECARE PVT. LTD.
Exhibit 147: NEXUS LIFECARE PVT. LTD. - Overview
Exhibit 148: NEXUS LIFECARE PVT. LTD. - Product / Service
Exhibit 149: NEXUS LIFECARE PVT. LTD. - Key offerings
12.15 Object Pharma Inc.
Exhibit 150: Object Pharma Inc. - Overview
Exhibit 151: Object Pharma Inc. - Product / Service
Exhibit 152: Object Pharma Inc. - Key offerings
12.16 Revance Therapeutics Inc.
Exhibit 153: Revance Therapeutics Inc. - Overview
Exhibit 154: Revance Therapeutics Inc. - Product / Service
Exhibit 155: Revance Therapeutics Inc. - Key offerings
12.17 SciVision Biotech Inc.
Exhibit 156: SciVision Biotech Inc. - Overview
Exhibit 157: SciVision Biotech Inc. - Product / Service
Exhibit 158: SciVision Biotech Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 159: Inclusions checklist
Exhibit 160: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 161: Currency conversion rates for US$
13.4 Research methodology
Exhibit 162: Research methodology
Exhibit 163: Validation techniques employed for market sizing
Exhibit 164: Information sources
13.5 List of abbreviations
Exhibit 165: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global botox market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Application - Market share 2023-2028 (%)
Exhibits 31: Data Table on Application - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Application
Exhibits 33: Data Table on Comparison by Application
Exhibits 34: Chart on Aesthetic - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Aesthetic - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Aesthetic - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Aesthetic - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Medical - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Medical - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Medical - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Medical - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Application ($ billion)
Exhibits 43: Data Table on Market opportunity by Application ($ billion)
Exhibits 44: Chart on End-user - Market share 2023-2028 (%)
Exhibits 45: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by End-user
Exhibits 47: Data Table on Comparison by End-user
Exhibits 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Dermatology clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Dermatology clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Dermatology clinics - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Dermatology clinics - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 57: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits 58: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 60: Market opportunity by End-user ($ billion)
Exhibits 61: Data Table on Market opportunity by End-user ($ billion)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Mexico - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on Mexico - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ billion)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 105: Impact of drivers and challenges in 2023 and 2028
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: AbbVie Inc. - Overview
Exhibits 112: AbbVie Inc. - Product / Service
Exhibits 113: AbbVie Inc. - Key news
Exhibits 114: AbbVie Inc. - Key offerings
Exhibits 115: BTXA - Overview
Exhibits 116: BTXA - Product / Service
Exhibits 117: BTXA - Key offerings
Exhibits 118: Daewoong Bio Inc. - Overview
Exhibits 119: Daewoong Bio Inc. - Product / Service
Exhibits 120: Daewoong Bio Inc. - Key offerings
Exhibits 121: Evolus Inc - Overview
Exhibits 122: Evolus Inc - Product / Service
Exhibits 123: Evolus Inc - Key offerings
Exhibits 124: FASTOX Pharma - Overview
Exhibits 125: FASTOX Pharma - Product / Service
Exhibits 126: FASTOX Pharma - Key offerings
Exhibits 127: Galderma SA - Overview
Exhibits 128: Galderma SA - Product / Service
Exhibits 129: Galderma SA - Key news
Exhibits 130: Galderma SA - Key offerings
Exhibits 131: Hugel Inc - Overview
Exhibits 132: Hugel Inc - Product / Service
Exhibits 133: Hugel Inc - Key offerings
Exhibits 134: Huons Global - Overview
Exhibits 135: Huons Global - Product / Service
Exhibits 136: Huons Global - Key offerings
Exhibits 137: Ipsen Pharma - Overview
Exhibits 138: Ipsen Pharma - Business segments
Exhibits 139: Ipsen Pharma - Key offerings
Exhibits 140: Ipsen Pharma - Segment focus
Exhibits 141: MedyTox Co. Ltd. - Overview
Exhibits 142: MedyTox Co. Ltd. - Product / Service
Exhibits 143: MedyTox Co. Ltd. - Key offerings
Exhibits 144: Merz Pharma GmbH and Co KGaA - Overview
Exhibits 145: Merz Pharma GmbH and Co KGaA - Product / Service
Exhibits 146: Merz Pharma GmbH and Co KGaA - Key offerings
Exhibits 147: NEXUS LIFECARE PVT. LTD. - Overview
Exhibits 148: NEXUS LIFECARE PVT. LTD. - Product / Service
Exhibits 149: NEXUS LIFECARE PVT. LTD. - Key offerings
Exhibits 150: Object Pharma Inc. - Overview
Exhibits 151: Object Pharma Inc. - Product / Service
Exhibits 152: Object Pharma Inc. - Key offerings
Exhibits 153: Revance Therapeutics Inc. - Overview
Exhibits 154: Revance Therapeutics Inc. - Product / Service
Exhibits 155: Revance Therapeutics Inc. - Key offerings
Exhibits 156: SciVision Biotech Inc. - Overview
Exhibits 157: SciVision Biotech Inc. - Product / Service
Exhibits 158: SciVision Biotech Inc. - Key offerings
Exhibits 159: Inclusions checklist
Exhibits 160: Exclusions checklist
Exhibits 161: Currency conversion rates for US$
Exhibits 162: Research methodology
Exhibits 163: Validation techniques employed for market sizing
Exhibits 164: Information sources
Exhibits 165: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global botox market: AbbVie Inc., Bausch Health Companies Inc., BTXA, Candela Corp., Daewoong Bio Inc., Eisai Co. Ltd., Evolus Inc, FASTOX Pharma, Galderma SA, Hugel Inc, Huons Global, Ipsen Pharma, MedyTox Co. Ltd., Merz Pharma GmbH and Co KGaA, NEXUS LIFECARE PVT. LTD., Object Pharma Inc., Revance Therapeutics Inc., SciVision Biotech Inc., Suneva Medical, and USWM LLC.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing importance of medical aesthetics.'

According to the report, one of the major drivers for this market is the increasing applications of botox in cosmetic and therapeutic procedures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • BTXA
  • Candela Corp.
  • Daewoong Bio Inc.
  • Eisai Co. Ltd.
  • Evolus Inc
  • FASTOX Pharma
  • Galderma SA
  • Hugel Inc
  • Huons Global
  • Ipsen Pharma
  • MedyTox Co. Ltd.
  • Merz Pharma GmbH and Co KGaA
  • NEXUS LIFECARE PVT. LTD.
  • Object Pharma Inc.
  • Revance Therapeutics Inc.
  • SciVision Biotech Inc.
  • Suneva Medical
  • USWM LLC